Compare IRTC & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRTC | HLNE |
|---|---|---|
| Founded | 2006 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.1B |
| IPO Year | 2016 | 2017 |
| Metric | IRTC | HLNE |
|---|---|---|
| Price | $177.96 | $135.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $204.64 | $160.89 |
| AVG Volume (30 Days) | 427.9K | ★ 545.2K |
| Earning Date | 02-19-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | ★ 19.80 |
| EPS | N/A | ★ 5.55 |
| Revenue | $702,573,000.00 | ★ $733,070,000.00 |
| Revenue This Year | $27.20 | $8.51 |
| Revenue Next Year | $16.91 | $20.20 |
| P/E Ratio | ★ N/A | $24.77 |
| Revenue Growth | ★ 25.45 | 13.01 |
| 52 Week Low | $86.19 | $111.98 |
| 52 Week High | $212.00 | $179.19 |
| Indicator | IRTC | HLNE |
|---|---|---|
| Relative Strength Index (RSI) | 53.39 | 61.57 |
| Support Level | $175.79 | $135.00 |
| Resistance Level | $182.38 | $140.12 |
| Average True Range (ATR) | 4.89 | 3.71 |
| MACD | 0.82 | 0.53 |
| Stochastic Oscillator | 70.30 | 68.87 |
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.